FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
University of Parma
Parma, ItaliaPublicaciones en colaboración con investigadores/as de University of Parma (9)
2023
-
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 2, pp. 198-205
2022
-
COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months
PLoS ONE, Vol. 17, Núm. 2 Febuary
-
Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients
European Journal of Surgical Oncology, Vol. 48, Núm. 4, pp. 857-863
-
Trends of Phase I Clinical Trials in the Latest Ten Years across Five European Countries
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 21
2019
-
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
PLoS ONE, Vol. 14, Núm. 11
2017
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Heart Rhythm, Vol. 14, Núm. 1, pp. e3-e40
2016
-
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication
Journal of Arrhythmia, Vol. 32, Núm. 4, pp. 247-278
-
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Europace, Vol. 18, Núm. 10, pp. 1455-1490